KAREN URBAN: Open Payments
NPI 1407319668 · VIRGINIA BEACH, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,217 in 98 payments from 21 companies in 2025. Trend: 2023 $2,023 · 2024 $1,603 · 2025 $2,217
Food & beverage: $2,217
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 23 | $568 |
| Takeda Pharmaceuticals U.S.A., Inc. | 14 | $269 |
| Janssen Biotech, Inc. | 7 | $248 |
| Ardelyx, Inc. | 10 | $201 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 5 | $117 |
| PFIZER INC. | 5 | $95 |
| Regeneron Healthcare Solutions, Inc. | 4 | $93 |
| Intercept Pharmaceuticals, Inc. | 3 | $71 |
| QOL Medical, LLC | 3 | $69 |
| Celltrion USA Inc. | 3 | $65 |
Products named: RINVOQ, ENTYVIO, TREMFYA, SKYRIZI, IBSRELA, XIFAXAN, DUPIXENT, OCALIVA.
Industry payments across VA — which companies pay providers there.
